Potential Advancement in Alzheimer’s Research: Results of a new trial uncovers a drug that slows cognitive decline in those diagnosed with Alzheimer’s
By: Jayme Fisher On Sept. 27, Eisai announced in a press release that the results of a trial saw a breakthrough in Alzheimer’s disease treatment. The drug used in the trial was lecanemab, which is an experimental monoclonal antibody designed to break down clumps of toxic proteins in the brain that are argued to be
